Rick Witte has a wealth of experience in pharmaceutical development and manufacturing, specifically in anti-sense microRNA formulations and siRNA drug products. With a background in materials science and biomedical engineering, Rick has held various leadership positions at companies such as HUYA Bioscience International, Regulus Therapeutics, and Isis Pharmaceuticals. Their expertise includes managing drug product development, solid-lipid nanoparticle formulation development, and process development for clinical trials.